B). p,0.05 (*), p,0.01 (**), p,0.001 (***) were considered significantly different. Acknowledgments We thank K. Eulenburg for excellent technical advice, L. Mendoza and S. Schneider for critically reading the manuscript, A. Scheffold, J.P. Allison, and D.Y. Loh for kindly providing our laboratory with reagents and mice. References 1. Campbell DJ, Kim CH, Butcher EC (2003) Chemokines in the systemic organization of immunity. Immunological Reviews 195: 58–71. 2. Hamann A, Engelhardt B (2005) Leukocyte trafficking. Weinheim: Wiley-VCH. 517 p. 3. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH (2003) Molecular mechanisms regulating Th1 immune responses. Annual Review of Immunology 21: 713–758. 4. Olsson T (1995) Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen-Specific T-Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple-Sclerosis. Immunological Reviews 144: 245–268. 5. Casares D, Brumeanu TD (2001) Insights into the pathogeneses of type I diabetes: a hint for novel immunospecific therapies. Curr Mol Med 1: 357–378. 6. Simon AK, Seipelt E, Sieper J (1994) Divergent T-Cell Cytokine Patterns in Inflammatory Arthritis. Proceedings of the National Academy of Sciences of the United States of America 91: 8562–8566. 7. Brunner M, Larsen S, Sette A, Mitchison A (1995) Altered Th1/Th2 balance associated with the immunosuppressive/protective effect of the H-2A(b) allele on the response to allo-4-hydroxyphenylpyruvate dioxygenase. European Journal of Immunology 25: 3285–3289. 8. Powrie F, Coffman RL (1993) Cytokine Regulation of T-Cell Function - Potential for Therapeutic Intervention. Immunology Today 14: 270–274. 9. Brunner MC, Chambers CA, Chan FK, Hanke J, Winoto A, et al. (1999) CTLA-4-Mediated inhibition of early events of T cell proliferation. J Immunol 162: 5813–5820. 10. Kirchhoff S, Muller WW, Li-Weber M, Krammer PH (2000) Up-regulation of c- FLIPshort and reduction of activation-induced cell death in CD28-co-stimulated human T cells. European Journal of Immunology 30: 2765–2774. 11. Pandiyan P, Gartner D, Soezeri O, Radbruch A, Schulze-Osthoff K, et al. (2004) CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J Exp Med 199: 831–842. 12. Kolar P, Knieke K, Hegel JK, Quandt D, Burmester GR, et al. (2009) CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum 60: 123–132. 13. Hoff H, Knieke K, Cabail Z, Hirseland H, Vratsanos G, et al. (2009) Surface CD152 (CTLA-4) Expression and Signaling Dictates Longevity of CD28null T Cells. JI. 14. Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, et al. (1996) The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev 153: 27–46. 15. Egen JG, Kuhns MS, Allison JP (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3: 611–618. 16. Maszyna F, Hoff H, Kunkel D, Radbruch A, Brunner-Weinzierl MC (2003) Diversity of clonal T cell proliferation is mediated by differential expression of CD152 (CTLA-4) on the cell surface of activated individual T lymphocytes. J Immunol 171: 3459–3466. 17. Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, et al. (1996) Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4: 535–543. 18. Egen JG, Allison JP (2002) Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16: 23–35. 19. Gimsa U, Oren A, Pandiyan P, Teichmann D, Bechmann I, et al. (2004) Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152). Journal of Molecular Medicine-Jmm 82: 364–372. 20. Dudda JC, Lembo A, Bachtanian E, Huehn J, Siewert C, et al. (2005) Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments. European Journal of Immunology 35: 1056–1065. 21. Mora JR, Cheng GY, Picarella D, Briskin M, Buchanan N, et al. (2005) Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. Journal of Experimental Medicine 201: 303–316. 22. Murdoch C (2000) CXCR4: chemokine receptor extraordinaire. Immunol Rev 177: 175–184. 23. Mackay CR (2001) Chemokines: immunology’s high impact factors. Nat Immunol 2: 95–101. 24. Stein JV, Rot A, Luo Y, Narasimhaswamy M, Nakano H, et al. (2000) The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid CD152 Promotes Migration We also like to thank G. Jorch and G.-R. Burmester for support and S.R. Fintushel for preparation of the manuscript. Author Contributions Conceived and designed the experiments: KK GFD MCBW. Performed the experiments: KK HH FM PK. Analyzed the data: KK. Contributed reagents/materials/analysis tools: AS AH. Wrote the paper: KK GFD MCBW. tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med 191: 61–76. 25. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, et al. (2002) Chemokine requirements for B cell entry to lymph nodes and Peyer’s patches. J Exp Med 196: 65–75. 26. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, et al. (2000) The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer’s patch high endothelial venules. J Exp Med 191: 77–88. 27. Chambers CA, Sullivan TJ, Truong T, Allison JP (1998) Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur J Immunol 28: 3137–3143. 28. Schenkel AR, Mamdouh Z, Muller WA (2004) Locomotion of monocytes on endothelium is a critical step during extravasation. Nature Immunology 5: 393–400. 29. Murphy PM (1994) The Molecular-Biology of Leukocyte Chemoattractant Receptors. Annual Review of Immunology 12: 593–633. 30. Krummel MF, Allison JP (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 182: 459–465. 31. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, et al. (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405–413. 32. Krummel MF, Allison JP (1996) CTLA-4 engagement inhibits IL-2 accumu- lation and cell cycle progression upon activation of resting T cells. J Exp Med 183: 2533–2540. 33. Scheffold A, Assenmacher M, Reiners-Schramm L, Lauster R, Radbruch A (2000) High-sensitivity immunofluorescence for detection of the pro- and anti- inflammatory cytokines gamma interferon and interleukin-10 on the surface of cytokine-secreting cells. Nat Med 6: 107–110. 34. Walunas TL, Bakker CY, Bluestone JA (1996) CTLA-4 ligation blocks CD28- dependent T cell activation. J Exp Med 183: 2541–2550. 35. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, et al. (1995) Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4. Science 270: 985–988. 36. Doyle AM, Mullen AC, Villarino AV, Hutchins AS, High FA, et al. (2001) Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells. Journal of Experimental Medicine 194: 893–902. 37. Scheffold A, Miltenyi S, Radbruch A (1995) Magnetofluorescent liposomes for increased sensitivity of immunofluorescence. Immunotechnology 1: 127–137. 38. Brunner-Weinzierl MC, Hoff H, Burmester GR (2004) Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases. Arthritis Research & Therapy 6: 45–54. 39. Schneider H, Mandelbrot DA, Greenwald RJ, Ng F, Lechler R, et al. (2002) Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4(+) T cells from receptor/ligand-deficient mice. Journal of Immunology 169: 3475–3479. 40. Schneider H, Valk E, Dias SD, Wei B, Rudd CE (2005) CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function. Proceedings of the National Academy of Sciences of the United States of America 102: 12861–12866. 41. Schneider H, Downey J, Smith A, Zinselmeyer BH, Rush C, et al. (2006) Reversal of the TCR stop signal by CTLA-4. Science 313: 1972–1975. 42. Mustelin T (2006) Restless T cells sniff and go. Science 313: 1902–1903. 43. Bleul CC, Schultze JL, Springer TA (1998) B Lymphocyte Chemotaxis Regulated in Association with Microanatomic Localization, Differentiation State, and B Cell Receptor Engagement. J Exp Med 187: 753–762. 44. Fedyk ER, Ryyan DH, Ritterman I, Springer TA (1999) Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1). J Leukoc Biol 66: 667–673. 45. Shen H, Cheng T, Olszak I, Garcia-Zepeda E, Lu Z, et al. (2001) CXCR-4 Desensitization Is Associated with Tissue Localization of Hemopoietic Progenitor Cells. J Immunol 166: 5027–5033. 46. Thelen M, Stein JV (2008) How chemokines invite leukocytes to dance. Nat Immunol 9: 953–959. 47. Marengere LE, Waterhouse P, Duncan GS, Mittrucker HW, Feng GS, et al. (1996) Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272: 1170–1173. PLoS ONE | www.plosone.org 10 May 2009 | Volume 4 | Issue 5 | e5702